1-4 of 4
Michael Brehm
Close
Sort by
Journal Articles

Myeloid Derived Suppressor Cells and Their Potential Impact on Minimal Residual Disease Status and Disease Response in a Cohort of Patients with Plasma Cell Dyscrasias

Andrew Wilks, Mohammed Wazir, Jonathan M. Gerber, Michael Brehm, Muthalagu Ramanathan
Journal: Blood
Blood (2023) 142 (Supplement 1): 6591.
https://doi.org/10.1182/blood-2023-190611
Published: 2023
Journal Articles

DR-01, a Non-Fucosylated Anti-CD94 Antibody, Depletes Leukemic Cells in Ex Vivo and In Vivo Models of Large Granular Lymphocyte Leukemia

Kelly Shi, Cindy Tan, Lu Bai, Jennifer Richardson, Andy Deng, Matthias Will, Michael Brehm, Dale Greiner, Leonard Shultz, Antonella Teramo, Renato Zambello, David J Feith, Thomas P. Loughran, Jr., Nenad Tomasevic
Journal: Blood
Blood (2022) 140 (Supplement 1): 2259–2260.
https://doi.org/10.1182/blood-2022-159242
Published: 2022
Journal Articles

Patient-Derived Xenografts (PDX) of B Cell Lymphoma in NSG Mice: A Mouse Avatar for Developing Personalized Medicine

Rachel Gerstein, PhD, Zheng Zhou, MD PhD, Hong Zhang, PhD, Andrew Evens, DO, MSc, FACP, Nicole Walsh, PhD, Leonard Shultz, Rita Bortell, PhD, Michael Brehm, PhD, Jan Cerny, MD PhD, Giles Whalen, MD, Jack Leonard, PhD, Bruce Woda, MD, Dale Greiner, PhD, Alan G. Rosmarin, MD
Journal: Blood
Blood (2015) 126 (23): 5408.
https://doi.org/10.1182/blood.V126.23.5408.5408
Published: 2015
Journal Articles

Enhanced Enrichment and Purification of Blood-Derived T-Cells Using a Novel Hydrogel Technology

Andrea Armstead, PhD, Sean Kevlahan, PhD, Darcy Reil, Rita Bortell, PhD, Michael Brehm, PhD
Journal: Blood
Blood (2015) 126 (23): 5437.
https://doi.org/10.1182/blood.V126.23.5437.5437
Published: 2015